Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | +0.32% | -11.27% | +152.00% |
May. 08 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
Apr. 16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+152.00% | 40.46M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Brian Quigley Will Not Stand for Re-Election of Lexaria Bioscience Corp.'s Board